Literature DB >> 25180401

Prevalence of restless legs syndrome and sleep quality in carriers of the fragile X premutation.

S M Summers, J Cogswell, J E Goodrich, Y Mu, D V Nguyen, S D Brass, R J Hagerman.   

Abstract

This study examined the relationship between the fragile X premutation and restless legs syndrome (RLS). Demographic, medical history and survey responses related to sleep were collected from 213 participants (127 carriers and 86 age matched controls). Subjects were asked about the presence of the four formal diagnostic criteria for RLS. Individuals with the premutation were 1.9 times as likely to meet criteria for RLS (95% CI 1.1–3.2, p=0.025) as controls. Premutation carriers with RLS also experienced significantly worse symptoms than matched controls with adjusted mean scores of 15.1±8.8 vs 7.9±4.4, respectively on the International Restless Legs Scale (IRLS). As markers for domains of sleep disturbance, all subjects completed the Epworth Sleepiness Scale (ESS), the Insomnia Severity Index (ISA) and the Pittsburgh Sleep Quality Index (PSQI). Premutation carriers demonstrated significantly more pathology on these tests except for the ESS where there was a trend towards increased daytime sleepiness in carriers. RLS joins a host of other conditions that should be carefully screened for in those carrying the fragile X premutation and sleep should be a focus for clinicians providing care to them.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25180401      PMCID: PMC4391968          DOI: 10.1111/cge.12249

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  19 in total

1.  Normal IPT and IBZM SPECT in drug-naive and levodopa-treated idiopathic restless legs syndrome.

Authors:  I Eisensehr; T C Wetter; R Linke; S Noachtar; H von Lindeiner; F J Gildehaus; C Trenkwalder; K Tatsch
Journal:  Neurology       Date:  2001-10-09       Impact factor: 9.910

2.  Validation of the Insomnia Severity Index as an outcome measure for insomnia research.

Authors:  C H. Bastien; A Vallières; C M. Morin
Journal:  Sleep Med       Date:  2001-07       Impact factor: 3.492

3.  Altered zinc transport disrupts mitochondrial protein processing/import in fragile X-associated tremor/ataxia syndrome.

Authors:  Eleonora Napoli; Catherine Ross-Inta; Sarah Wong; Alicja Omanska-Klusek; Cedrick Barrow; Christine Iwahashi; Dolores Garcia-Arocena; Danielle Sakaguchi; Elizabeth Berry-Kravis; Randi Hagerman; Paul J Hagerman; Cecilia Giulivi
Journal:  Hum Mol Genet       Date:  2011-05-10       Impact factor: 6.150

4.  Familial X-linked mental retardation with an X chromosome abnormality.

Authors:  J Harvey; C Judge; S Wiener
Journal:  J Med Genet       Date:  1977-02       Impact factor: 6.318

5.  Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox.

Authors:  Y H Fu; D P Kuhl; A Pizzuti; M Pieretti; J S Sutcliffe; S Richards; A J Verkerk; J J Holden; R G Fenwick; S T Warren
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

6.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

7.  Symptoms of restless legs syndrome in older adults: outcomes on sleep quality, sleepiness, fatigue, depression, and quality of life.

Authors:  Norma G Cuellar; Neville E Strumpf; Sarah J Ratcliffe
Journal:  J Am Geriatr Soc       Date:  2007-09       Impact factor: 5.562

8.  Absence of expression of the FMR-1 gene in fragile X syndrome.

Authors:  M Pieretti; F P Zhang; Y H Fu; S T Warren; B A Oostra; C T Caskey; D L Nelson
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

9.  Sequestration of DROSHA and DGCR8 by expanded CGG RNA repeats alters microRNA processing in fragile X-associated tremor/ataxia syndrome.

Authors:  Chantal Sellier; Fernande Freyermuth; Ricardos Tabet; Tuan Tran; Fang He; Frank Ruffenach; Violaine Alunni; Herve Moine; Christelle Thibault; Adeline Page; Flora Tassone; Rob Willemsen; Matthew D Disney; Paul J Hagerman; Peter K Todd; Nicolas Charlet-Berguerand
Journal:  Cell Rep       Date:  2013-03-07       Impact factor: 9.423

10.  FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States.

Authors:  Flora Tassone; Ka Pou Iong; Tzu-Han Tong; Joyce Lo; Louise W Gane; Elizabeth Berry-Kravis; Danh Nguyen; Lisa Y Mu; Jennifer Laffin; Don B Bailey; Randi J Hagerman
Journal:  Genome Med       Date:  2012-12-21       Impact factor: 11.117

View more
  12 in total

Review 1.  Implications of the FMR1 Premutation for Children, Adolescents, Adults, and Their Families.

Authors:  Anne Wheeler; Melissa Raspa; Randi Hagerman; Marsha Mailick; Catharine Riley
Journal:  Pediatrics       Date:  2017-06       Impact factor: 7.124

Review 2.  Sleep Disorders in Hereditary Ataxias.

Authors:  Lucio Huebra; Fernando Morgadinho Coelho; Flávio Moura Rezende Filho; Orlando G Barsottini; José Luiz Pedroso
Journal:  Curr Neurol Neurosci Rep       Date:  2019-07-25       Impact factor: 5.081

3.  Interaction between ventricular expansion and structural changes in the corpus callosum and putamen in males with FMR1 normal and premutation alleles.

Authors:  Jun Yi Wang; David Hessl; Flora Tassone; Kyoungmi Kim; Randi J Hagerman; Susan M Rivera
Journal:  Neurobiol Aging       Date:  2019-09-24       Impact factor: 4.673

Review 4.  Fragile X spectrum disorders.

Authors:  Reymundo Lozano; Carolina Alba Rosero; Randi J Hagerman
Journal:  Intractable Rare Dis Res       Date:  2014-11

Review 5.  Fragile X-associated tremor/ataxia syndrome - features, mechanisms and management.

Authors:  Randi J Hagerman; Paul Hagerman
Journal:  Nat Rev Neurol       Date:  2016-06-24       Impact factor: 42.937

6.  Towards an Understanding of Neuropsychiatric Manifestations in Fragile X Premutation Carriers.

Authors:  Aaron D Besterman; Scott A Wilke; Tua-Elisabeth Mulligan; Stephen C Allison; Randi Hagerman; Andreea L Seritan; James A Bourgeois
Journal:  Future Neurol       Date:  2014-03

7.  Molecular Advances Leading to Treatment Implications for Fragile X Premutation Carriers.

Authors:  Jonathan Polussa; Andrea Schneider; Randi Hagerman
Journal:  Brain Disord Ther       Date:  2014

8.  Endocrine Dysfunction in Female FMR1 Premutation Carriers: Characteristics and Association with Ill Health.

Authors:  Sonya Campbell; Sarah E A Eley; Andrew G McKechanie; Andrew C Stanfield
Journal:  Genes (Basel)       Date:  2016-11-18       Impact factor: 4.096

Review 9.  Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Pathophysiology and Clinical Implications.

Authors:  Ana Maria Cabal-Herrera; Nattaporn Tassanakijpanich; Maria Jimena Salcedo-Arellano; Randi J Hagerman
Journal:  Int J Mol Sci       Date:  2020-06-20       Impact factor: 5.923

Review 10.  Associated features in females with an FMR1 premutation.

Authors:  Anne C Wheeler; Donald B Bailey; Elizabeth Berry-Kravis; Jan Greenberg; Molly Losh; Marsha Mailick; Montserrat Milà; John M Olichney; Laia Rodriguez-Revenga; Stephanie Sherman; Leann Smith; Scott Summers; Jin-Chen Yang; Randi Hagerman
Journal:  J Neurodev Disord       Date:  2014-07-30       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.